iShares Biotechnology ETF (NASDAQ:IBB) Sees Large Growth in Short Interest

iShares Biotechnology ETF (NASDAQ:IBB) was the recipient of a large increase in short interest in November. As of November 30th, there was short interest totalling 11,260,000 shares, an increase of 9.5% from the November 15th total of 10,280,000 shares. Based on an average daily trading volume, of 1,231,300 shares, the days-to-cover ratio is currently 9.1 days.

iShares Biotechnology ETF Price Performance

IBB stock traded down $1.06 on Friday, reaching $136.61. The company had a trading volume of 1,400,321 shares, compared to its average volume of 1,448,945. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The company’s fifty day moving average is $141.84 and its 200 day moving average is $142.38.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in IBB. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $29,000. Highline Wealth Partners LLC acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $30,000. Ashton Thomas Securities LLC acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $36,000. Voisard Asset Management Group Inc. acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $59,000. Finally, Aptus Capital Advisors LLC grew its stake in shares of iShares Biotechnology ETF by 36.5% during the third quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock valued at $62,000 after acquiring an additional 114 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.